Print This Page Email This Page Share on LinkedIn Copyright Permissions Comment on This Story Custom Reprints Current Issue View Archives More Green Issues SURVEY: Only 26% of Chemical Companies Have Effective Marketing StrategySabic Slashing Production in EuropeChina's Ethylene Growth Will Slow Sharply in 2009DuPont Cutting 2,500 Jobs; Sees Fourth Quarter LossM&A: More Acquisition Deals Set to be Renegotiated Downward Related Stories Carbon Capture Technologies Challenged as "Unproven, Risky and Expensive"SAFC Injects $30 Million to Build Pharma Ingredients CapacityGenencor and Goodyear to Spend More than $50 Million Codeveloping Bio-isoprene ProcessPfizer Seeks to Reduce Solvent UseGreen Chemistry

People & Business :: Green Issues

August 6, 2008

Monsanto Seeks Buyer for Controversial Milk-Boosting Drug

Alex Scott

Monsanto disclosed today that it is looking for a buyer for its bovine milk boosting drug Posilac recombinant bovine somatotropin (rBST). Monsanto did not disclose if it was yet in talks with a prospective buyer or how much it is seeking for the business...

This information is only available to
Chemical Week 24/7 members and subscribers.

Forgot your user ID or password?
Click here to have it sent to you.

Email Address First Name Last Name

Not a Chemical Week 24/7 member yet? Here's why you should be: Searchable online archive        access of the last 2 years        of Chemical Week. Print or digital magazine subscription Price and market change alerts Economic data and statistics Buyers' Guides Webcasts | whitepapers